Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Cel-Sci Corp. (CVM)
NYSE MKT:CVM
Cel-Sci (CVM) Stock Price & Analysis
630 Followers
CVM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.88 - $6.14
Previous Close$2.3
Volume69.75K
Average Volume (3M)131.88K
Market Cap
$100.60M
Enterprise Value$93.23M
Total Cash (Recent Filing)$22.67M
Total Debt (Recent Filing)$15.30M
Price to Earnings (P/E)-2.7
Beta1.40
Next Earnings
May 16, 2023EPS Estimate
-$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding43,738,865
10 Day Avg. Volume114,168
30 Day Avg. Volume131,882
Standard Deviation0.43
R-Squared0.05
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)3.75
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.00
Forecast
1Y Price Target
$10.00Price Target Upside331.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cel-Sci News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CVM FAQ
What was Cel-Sci Corp.’s price range in the past 12 months?
Cel-Sci Corp. lowest stock price was $1.88 and its highest was $6.14 in the past 12 months.
What is Cel-Sci Corp.’s market cap?
Currently, no data Available
When is Cel-Sci Corp.’s upcoming earnings report date?
Cel-Sci Corp.’s upcoming earnings report date is May 16, 2023 which is in 46 days.
How were Cel-Sci Corp.’s earnings last quarter?
Cel-Sci Corp. released its earnings results on Feb 15, 2023. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.02.
Is Cel-Sci Corp. overvalued?
According to Wall Street analysts Cel-Sci Corp.’s price is currently Undervalued.
Does Cel-Sci Corp. pay dividends?
Cel-Sci Corp. does not currently pay dividends.
What is Cel-Sci Corp.’s EPS estimate?
Cel-Sci Corp.’s EPS estimate is -$0.17.
How many shares outstanding does Cel-Sci Corp. have?
Cel-Sci Corp. has 43,738,865 shares outstanding.
What happened to Cel-Sci Corp.’s price movement after its last earnings report?
Cel-Sci Corp. reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went down -0.376%.
Which hedge fund is a major shareholder of Cel-Sci Corp.?
Among the largest hedge funds holding Cel-Sci Corp.’s share is Perceptive Advisors LLC. It holds Cel-Sci Corp.’s shares valued at N/A.
---
Cel-Sci Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (331.03% Upside)
$10.00 (331.03% Upside)
Blogger Sentiment
Bearish
CVM Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 33.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.34%
12-Months-Change
Fundamentals
Return on Equity
-91.79%
Trailing 12-Months
Asset Growth
-36.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cel-Sci Corp.
CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
---
Top 5 ETFs holding CVM
iShares Core S&P Total U.S. Stock Market ETF
$142.38
Up to five ETFs with an Outperform Smart Score that hold CVM. The ETFs are listed according to market value of CVM within the ETF
---
Ovid Therapeutics
―
X4 Pharmaceuticals
―
KalVista Pharmaceuticals
―
Enzolytics
―
Medicinova
―
---